Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.97 |
| ▸ | BLM | P54132 | 4/20 | 0.97 |
| ▸ | APAF1 | O14727 | 1/20 | 0.97 |
| ▸ | NPC1 | O15118 | 1/20 | 0.97 |
| ▸ | POLB | P06746 | 1/20 | 0.97 |
| ▸ | RAB9A | P51151 | 1/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | CASP1 | P29466 | 4/20 | 0.67 |
| ▸ | CASP7 | P55210 | 4/20 | 0.67 |
| ▸ | THRB | P10828 | 3/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | BRCA1 | P38398 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26848576 | 1.00 | MEN1 (0.97) | MEN1KMT2ABLMAPAF1NPC1 | |
| SCHEMBL7762151 | 0.98 | MEN1 (0.94) | MEN1KMT2ABLMAPAF1NPC1 | |
| Bromide SCHEMBL592713 | 0.98 | MEN1 (1.00) | MEN1KMT2ABLMAPAF1NPC1 | |
| Water SCHEMBL864813 | 0.97 | MEN1 (0.97) | MEN1KMT2ABLMAPAF1NPC1 | |
| SCHEMBL8777304 | 0.85 | MEN1 (0.70) | MEN1KMT2ABLMAPAF1NPC1 | |
| SCHEMBL15432842 | 0.83 | MEN1 (0.68) | MEN1KMT2ABLMAPAF1NPC1 | |
| SCHEMBL28027342 | 0.82 | MEN1 (0.67) | MEN1KMT2ABLMAPAF1NPC1 | |
| Hydrochloric Acid SCHEMBL7167595 | 0.82 | MEN1 (0.67) | MEN1KMT2ABLMAPAF1NPC1 | |
| Homidium SCHEMBL27609 | 0.80 | MEN1 (1.00) | MEN1KMT2ABLMAPAF1NPC1 | |
| Homidium SCHEMBL31511751 | 0.80 | MEN1 (1.00) | MEN1KMT2ABLMAPAF1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137806-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | claimed |
| EP-4525855-A1 | INTERCALATING SUGAR MOLECULES | Xalud Therapeutics, Inc. (US) | 2025-03-26 | — | — | EP | claimed |
| WO-2023225631-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| EP-2516995-B1 | SERS-BASED ANALYTE DETECTION | AGENCY SCIENCE TECH & RES (SG) | 2016-10-26 | — | — | EP | claimed |
| EP-2516995-A1 | SERS-BASED ANALYTE DETECTION | Agency For Science, Technology And Research (SG) | 2012-10-31 | — | — | EP | claimed |
| WO-2011078794-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-30 | — | — | WO | claimed |
| US-5989809-A | Methods for detecting a polynucleotide using an inactivating reagent and composition and kit comprising same | ENZO DIAGNOSTICS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| EP-0231495-B1 | One-step method and polynucleotide compounds for hybridizing to target polynucleotides | ENZO BIOCHEM INC (US) | 1999-06-16 | — | — | EP | claimed |
| EP-0916737-A2 | Polynucleotide compounds for hybridizing to target polynucleotides | ENZO BIOCHEM, INC. (US) | 1999-05-19 | — | — | EP | claimed |
| EP-0454461-B1 | Selective amplification system using Q beta replicase, a hybridization assay and a method of detecting and assessing concentration of target nucleic acid in liquid samples | GENE TRAK SYSTEMS CORP (US) | 1996-06-19 | — | — | EP | claimed |
| EP-0382958-B1 | Surfactant sensing electrode for potentiometric titrations | CLOROX CO (US) | 1993-10-27 | — | — | EP | claimed |
| EP-0382958-A1 | Surfactant sensing electrode for potentiometric titrations | The Clorox Company (US) | 1990-08-22 | — | — | EP | claimed |
| US-20260137806-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4525855-A1 | INTERCALATING SUGAR MOLECULES | Xalud Therapeutics, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023225631-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023177976-A2 | NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF | PROMEGA CORPORATION (US) | 2023-09-21 | — | — | WO | disclosed |
| US-4948473-A | ELECTROCONDUCTIVE CORE, SEMIPERMEABLE MEMBRANE INCLUDING A POLYMER, PLASTICIZER, AND AN ION EXCHAMGER | THE CLOROX COMPANY (US) | 1990-08-14 | — | — | US | disclosed |
| US-4810331-A | SEMIPERMEABLE MEMBRANE, ION EXCHANGER | THE CLOROX COMPANY (US) | 1989-03-07 | — | — | US | disclosed |
| EP-0231495-A2 | One-step method and polynucleotide compounds for hybridizing to target polynucleotides | ENZO BIOCHEM, INC. (US) | 1987-08-12 | — | — | EP | disclosed |
| EP-0193414-A2 | Liposomes, process for their preparation and compositions containing them | Fluck, David John (ZW) | 1986-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137806-A1 | INTERCALATING SUGAR MOLECULES | SLC2A1, SLC2A2, SLC2A4 | MEN1 1689/4885KMT2A 3581/4885BLM 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.